We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-21.35%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2.43B
AUM Growth
-$314M
Cap. Flow
-$88.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
48.1%
Holding
447
New
130
Increased
120
Reduced
90
Closed
66

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$38.8M
2
BIIB icon
Biogen
BIIB
+$26M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$23.3M
4
VTRS icon
Viatris
VTRS
+$21M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$16.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$28.9M
2
MRK icon
Merck
MRK
+$17.9M
3
XOM icon
ExxonMobil
XOM
+$14.8M
4
ZGNX
Zogenix, Inc.
ZGNX
+$13.4M
5
LPCN icon
Lipocine
LPCN
+$7.13M

Sector Composition

Rank Sector Weight
1 Healthcare 13.39%
2 Energy 1.08%
3 Technology 0.46%
4 Materials 0.45%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
376
Ardelyx
ARDX
$1.25B
– –
-13,757
Closed -$220K
ASND icon
377
Ascendis Pharma A/S
ASND
$16.7B
– –
-160,000
Closed -$2.81M
BCRX icon
378
CALL
BioCryst Pharmaceuticals
BCRX
$2.48B
– –
-1,722
Closed -$2.57M
CHRS icon
379
Coherus Oncology
CHRS
$222M
– –
-30,000
Closed -$867K
CYH icon
380
CALL
Community Health Systems
CYH
$393M
– –
-309
Closed -$1.61M
ESPR
381
PUT
DELISTED
Esperion Therapeutics
ESPR
– –
-399
Closed -$3.26M
EXAS
382
CALL
DELISTED
Exact Sciences
EXAS
– –
-3,007
Closed -$8.94M
HCA icon
383
PUT
HCA Healthcare
HCA
$92.8B
– –
-324
Closed -$2.94M
HUM icon
384
CALL
Humana
HUM
$46.7B
– –
-500
Closed -$9.56M
ITP icon
385
PUT
IT Tech Packaging
ITP
$2.92M
– –
-10
Closed -$17K
LSTA icon
386
Lisata Therapeutics
LSTA
$10.6M
– –
-3,169
Closed -$889K
MRK icon
387
CALL
Merck
MRK
$326B
– –
-10,480
Closed -$56.9M
MRK icon
388
Merck
MRK
$326B
– –
-329,371
Closed -$17.9M
MRK icon
389
PUT
Merck
MRK
$326B
– –
-5,485
Closed -$29.8M
REGN icon
390
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
– –
-304
Closed -$15.5M
SRPT icon
391
Sarepta Therapeutics
SRPT
$1.63B
– –
-71,600
Closed -$2.43M
TENX icon
392
CALL
Tenax Therapeutics
TENX
$419M
– –
0
– -$12.2M
TEVA icon
393
CALL
Teva Pharmaceuticals
TEVA
$36.9B
– –
-54
Closed -$319K
TEVA icon
394
Teva Pharmaceuticals
TEVA
$36.9B
– –
-4,173
Closed -$247K
TEVA icon
395
PUT
Teva Pharmaceuticals
TEVA
$36.9B
– –
-5,210
Closed -$30.8M
TLT icon
396
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
– –
-246,000
Closed -$28.9M
TRUP icon
397
Trupanion
TRUP
$1.11B
– –
-161,012
Closed -$1.33M
XLV icon
398
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
– –
-5,998
Closed -$44.6M
XOMA
399
PUT
DELISTED
Xoma
XOMA
– –
-59
Closed -$458K
XOM icon
400
ExxonMobil
XOM
$634B
– –
-178,310
Closed -$14.8M
14 15
16
17 18

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sabby Management held 447 positions worth $2.43B, down 11% from $2.74B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sabby Management withdrew a net $88.1M in Q3 2015, closing 66 positions and reducing 90 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $28.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.3% a quarter earlier, followed by Energy and Technology.

Against the trend, Sabby Management opened a new position in iShares Russell 2000 ETF worth $35.7M.

  • Sabby Management's largest Q3 2015 buy was iShares Russell 2000 ETF: 327,168 shares worth $35.7M.
  • Sabby Management added most to Mobileye N.V. in Q3 2015, an estimated $8.9M increase.
  • Sabby Management's biggest Q3 2015 reduction was Lipocine, cutting an estimated $7.13M.
  • Sabby Management fully exited iShares 20+ Year Treasury Bond ETF in Q3 2015, selling an estimated $28.9M.
  • Sabby Management's ten largest holdings make up 48% of its $2.43B portfolio in Q3 2015.
  • Sabby Management opened 130 new positions and closed 66 in Q3 2015.
  • Sabby Management's portfolio value fell 11% quarter-over-quarter to $2.43B.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.